共 456 条
[1]
Fisher B(1997)Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18 J Clin Oncol 15 2483-2493
[2]
Brown A(1998)A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer Ann Oncol 9 1179-1184
[3]
Mamounas E(1999)Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonie Bordeaux Groupe Sein (IBBGS) Ann Oncol 10 47-52
[4]
Wieand S(2005)Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis J Natl Cancer Inst 97 188-194
[5]
Robidoux A(2007)Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer Cancer 110 244-254
[6]
Margolese RG(2008)Locally advanced and inflammatory breast cancer J Clin Oncol 26 786-790
[7]
Cruz AB(2012)Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes J Clin Oncol 30 1796-1804
[8]
Fisher ER(2000)Prediction of clinical outcome from primary tamoxifen by expression of biologic markers in breast cancer patients Clin Cancer Res 6 616-621
[9]
Wickerham DL(2013)Molecular subtyping of early-stage breast cancer identifies a group of patients who do not benefit from neoadjuvant chemotherapy Breast Cancer Res Treat 139 759-767
[10]
Wolmark N(2016)Neoadjuvant endocrine therapy for estrogen receptor-positive breast cancer: a systematic review and meta-analysis JAMA Oncol 2 1477-1486